• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Citrate in urine and serum and associated variables in subgroups of urolithiasis. Results from an outpatient stone clinic.

作者信息

Schwille P O, Scholz D, Schwille K, Leutschaft R, Goldberg I, Sigel A

出版信息

Nephron. 1982;31(3):194-202. doi: 10.1159/000182646.

DOI:10.1159/000182646
PMID:7121665
Abstract

Outpatient renal stone formers belonging to the established urolithiasis subgroups and controls were examined with respect to urinary and serum citrate (Cit) and several associated variables. Only in the normocalciuric majority of calcium and in uric acid stone formers was Cit in 24-hour urine decreased, but was normal in 2-hour fasting morning, and in 3-hour postprandial urine following a Cit-free test meal. Serum Cit was elevated in normocalciuria, renal and resorptive hypercalciuria. This Cit constellation was associated with either normal (absorptive, renal hypercalciuria) or low (normocalciuria, uric acid stone formers) parathyroid gland function as assessed by serum parathyroid hormone and nephrogenous urinary cyclic AMP, except in patients with primary hyperparathyroidism. In 2-hour morning urine the magnesium/creatinine ratio (normocalciuria) and ammonia excretion (uric acid stone formers) were decreased, while ammonia in 24-hour urine was low in all stone formers. It is suggested that Cit metabolism is altered in renal stone disease in general, and that in normocalciuria, stone inhibitors (Cit; magnesium) may be deficient.

摘要

相似文献

1
Citrate in urine and serum and associated variables in subgroups of urolithiasis. Results from an outpatient stone clinic.
Nephron. 1982;31(3):194-202. doi: 10.1159/000182646.
2
Ultrafiltrable serum citrate and the relationship between serum and urinary citrate results in controls and renal calcium stone formers.可超滤血清柠檬酸盐以及对照组和肾钙结石形成者中血清与尿柠檬酸盐结果之间的关系。
J Clin Chem Clin Biochem. 1982 Apr;20(4):169-73. doi: 10.1515/cclm.1982.20.4.169.
3
Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.肾结石形成的尿液危险因素的饮食治疗。CLU工作组综述
Arch Ital Urol Androl. 2015 Jul 7;87(2):105-20. doi: 10.4081/aiua.2015.2.105.
4
Composition of renal stones and their frequency in a stone clinic: relationship to parameters of mineral metabolism in serum and urine.肾结石门诊中肾结石的成分及其发生率:与血清和尿液中矿物质代谢参数的关系
Urol Res. 1979 Sep;7(3):161-70. doi: 10.1007/BF00257201.
5
Serum and 24-hour urinary tests cost-effectiveness in stone formers.结石形成者的血清和 24 小时尿液检测的成本效益。
BMC Urol. 2023 Aug 27;23(1):141. doi: 10.1186/s12894-023-01310-w.
6
Role of citric acid in primary hyperparathyroidism with renal lithiasis.柠檬酸在原发性甲状旁腺功能亢进合并肾石症中的作用。
Urol Res. 1992;20(1):88-90. doi: 10.1007/BF00294345.
7
Effects of magnesium hydroxide in renal stone disease.氢氧化镁在肾结石疾病中的作用。
J Am Coll Nutr. 1982;1(2):179-85. doi: 10.1080/07315724.1982.10718985.
8
Urinary risk factors for recurrent calcium stone formation in Thai stone formers.泰国结石患者复发性钙结石形成的尿液危险因素。
J Med Assoc Thai. 2007 Apr;90(4):688-98.
9
Quantitative element investigations in urine, serum, kidney and muscle tissue of calcium oxalate stone patients.草酸钙结石患者尿液、血清、肾脏及肌肉组织中的定量元素研究。
Eur Urol. 1978;4(3):206-11. doi: 10.1159/000473951.
10
Agglomeration inhibition reflected stone-forming activity during long-term potassium citrate therapy in calcium stone formers.在长期服用柠檬酸钾治疗钙结石患者的过程中,凝聚抑制反映了结石形成活性。
Urology. 1998 Dec;52(6):988-94. doi: 10.1016/s0090-4295(98)00361-6.

引用本文的文献

1
Effect of potential renal acid load of foods on urinary citrate excretion in calcium renal stone formers.食物潜在肾酸负荷对含钙肾结石患者尿枸橼酸盐排泄的影响。
Urol Res. 2006 Feb;34(1):1-7. doi: 10.1007/s00240-005-0001-9. Epub 2006 Jan 20.
2
Absence or decreased endogenous thiosulfaturia: a cause of recurrent calcium nephrolithiasis.内源性硫代硫酸盐尿缺失或减少:复发性钙肾结石的一个病因。
Int Urol Nephrol. 2004;36(4):587-9. doi: 10.1007/s11255-004-8786-y.
3
Gestational urinary hyperthiosulfaturia protects hypercalciuric normal pregnant women from nephrolithiasis.
妊娠期尿高硫代硫酸盐尿症可保护高钙尿症的正常孕妇免受肾结石的影响。
Int Urol Nephrol. 2004;36(3):445-9. doi: 10.1007/s11255-004-8784-0.
4
Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation.草酸钙结晶的尿中抑制剂及其在结石形成中的潜在作用。
World J Urol. 1997;15(3):155-64. doi: 10.1007/BF02201852.
5
Urinary excretion of calcium, magnesium, oxalate and citrate in duodenal ulcer patients. Preliminary results before and up to five years after highly selective vagotomy.十二指肠溃疡患者钙、镁、草酸盐和柠檬酸盐的尿排泄情况。高选择性迷走神经切断术前及术后长达五年的初步结果。
Klin Wochenschr. 1983 Sep 1;61(17):845-50. doi: 10.1007/BF01537459.
6
Parathyroid gland function in subgroups of metabolically mediated urolithiasis as evaluated by serum parathyroid hormone, and urinary and nephrogenous cyclic nucleotides.
Klin Wochenschr. 1982 Mar 1;60(5):229-36. doi: 10.1007/BF01728341.
7
Determination of GOT activity on nucleation and crystal growth of calcium oxalate.谷草转氨酶活性对草酸钙成核和晶体生长的影响测定
Urol Res. 1984;12(4):223-6. doi: 10.1007/BF00256808.
8
Acute oral alkali citrate load in healthy humans--response of blood and urinary citrate, mineral metabolism, and factors related to stone formation.
Urol Res. 1985;13(4):161-8. doi: 10.1007/BF00261817.
9
The importance of diet in urinary stones.
Urol Res. 1986;14(6):283-8. doi: 10.1007/BF00262376.
10
Urine citrate and renal stone disease.尿枸橼酸盐与肾结石病
CMAJ. 1989 Aug 1;141(3):217-21.